This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022
Title: Daniel Sazer: Innovator in Nucleic Acid Screening
Introduction
Daniel Sazer is an accomplished inventor based in Newton, MA (US). He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid sequence variations. His innovative approach has the potential to enhance the efficiency of genetic screening processes.
Latest Patents
Daniel Sazer holds a patent for "Screening of nucleic acid sequence variations via random loading of optically-encoded particles." This patent describes methods and reagents for high-throughput screening of nucleic acid sequence variations in specimens. The process involves loading nucleic acid specimens into separate discrete volumes and using optically encoded particles to deliver primers for amplification. The random delivery of these particles allows for a unique combination in each well, facilitating the identification of discrete volumes based on observable combinations.
Career Highlights
Throughout his career, Daniel Sazer has worked with prestigious organizations such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include David Feldman and Paul Blainey. Their collaborative efforts have further advanced the research and applications of nucleic acid screening technologies.
Conclusion
Daniel Sazer's innovative work in nucleic acid screening exemplifies the impact of modern inventions in the field of molecular biology. His contributions continue to pave the way for advancements in genetic research and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile